IC
MDXG icon

Innealta Capital’s MiMedx Group MDXG Stock Holding History

Innealta Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-126
Closed -$873 – 1054
2024
Q2 		$873 Buy
+126
New +$886 ﹤0.01% 1348

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Innealta Capital's MDXG Position: Q3 2024 in Review

Innealta Capital sold out of MiMedx Group (MDXG) in Q3 2024, closing a stake of 126 shares — an estimated $873 sold.

Innealta Capital first reported a position in MDXG in Q2 2024 and held it in 1 quarter. The position peaked at $873 in Q2 2024. 194 funds tracked by Wall St. Rank hold MDXG as of Q3 2024.

  • Innealta Capital reported no remaining MiMedx Group position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 126 MiMedx Group shares in Q3 2024, an estimated $873.
  • Innealta Capital first reported a position in MiMedx Group in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's MiMedx Group position peaked at $873 in Q2 2024.
  • 194 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.